Ossylbone™

Product Description

Ossylbone™ is a fully biocompatible, biodegradable and safe material that mimics the natural bone structure and by that its able to effectively support the regeneration of the bone tissue.The Ossylbone™ as an alloplast material is bone substitute material obtained through laboratory chemical synthesis, what guarantee its full control over its chemical and physical properties. Ossylbone™ biomimetic bone substitute is composed of hydroxyapatite (HAp) (75%) and tricalcium phosphate (β-TCP) (25%), resembling the inorganic phase of bone tissue extracellular matrix. As a result of its origin Ossylbone™ can be produced in a vast range of forms, resulting in broad range of application.

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices
Specifications
  • Details
    Ossylbone™ biomimetic bone substitute is designed for a broad range of clinical situations requiring fast and predictable bone tissue regeneration. Thanks to its high biocompatibility, bioresorbability and osteoconductivity, the material provides reliable structural support throughout the bone regeneration process.
    The product is intended for:
  • filling bone defects resulting from various types of fractures,
  • filling the space left after removal of bone pathologies or bone cysts,
  • restoring bone loss following tooth extraction and in dental procedures requiring bone augmentation.
  • Selling Points
    Bone & Joint Health;
  • Biomimetic design – synthesized under fully controlled laboratory conditions to closely resemble the physical and chemical properties of natural human bone.
  • Optimized porosity – porosity ranging from 50% to 90%, with micro- and macropores between <20µm and 500µm, replicating natural bone structure and supporting proper osteoconductivity.
  • Bone-matching chemical composition – based on hydroxyapatite (HAp) and tricalcium phosphate (β-TCP), two of the main components of the bone tissue extracellular matrix.
  • Additional calcium source – naturally resorbable β-TCP supplies calcium ions essential for bone regeneration, further supporting osteoconductivity.
  • Optional chitosan-enhanced formulations – improve biomaterial-to-bone adhesion and offer bacteriostatic and anti-inflammatory properties.
  • Full biocompatibility and bioresorbability – forms a strong, permanent connection with surrounding bone tissue.
  • Model
    granules
  • Supplied from
    Poland
  • Sales Markets

    Biovico Sp. z o.o.

    • Country/Region:
      Poland
    • Founded:
      2008
    • On CPHI since:
      2015
    • Certificates:
      5
    • Employees:
      100 - 249
    Company types
    CMO/CDMO
    Licensee
    Manufacturer/Innovator
    Wholesale/Retail
    Primary activities
    Medical Devices

    More Products from Biovico Sp. z o.o. (12)

    • Monoshot™ HA+PRP

      Product Monoshot™ HA+PRP

      Monoshot™ HA+PRP is an innovative kit combining hyaluronic acid (HA) with platelet-rich plasma (PRP) for intra-articular injection therapy. HA delivers mechanical lubrication and anti-inflammatory action by reducing matrix metalloproteinase production, while PRP — prepared using the dedicated Monoshot™ sep...
    • Xerthra™ BMAC

      Product Xerthra™ BMAC

      Xerthra™ BMAC is an innovative procedure set for separating and concentrating bone marrow aspirate to obtain a concentrated bone marrow fraction (BMAC), used for local injection to enhance tissue regeneration. Its uniquely designed separation devices deliver BMAC with 5 times more concentrated mesenchymal ...
    • AOORA™ kits

      Product AOORA™ kits

      Three AOORA™ procedure packs designed for isolation and separation of high quality blood derived products. The obtained platelet-rich plasma (PRP) contains minimum 1 milion of platelets in 1 μl of plasma, which has the direct impact on the high amount of growth factors delivered in order to revitalize skin...
    • Flavya™ Post Treatment products

      Product Flavya™ Post Treatment products

      Flavya™ Post-Treatment Products are biocellulose-based medical devices infusedwith hyaluronic acid. Due to their occlusive properties, they form a protective barrieron the skin, which is particularly beneficial after medical esthetic treatments.Additionally, their cooling effect helps soothe irritation and...
    • Supplements

      Product Supplements

      Biolevox™ Complex (90 film-coated capsules) supplements the diet with ingredients found in joint structures thus supports the their functioning.
      Chondrovox™ (60 capsules) formulation contains chondroitin sulfate that occurs naturally in joint cartilage. Chondroitin supplementation sup...
    • Progum™

      Product Progum™

      Progum™ is a hyaluronic acid-based product line supporting regeneration in dental and periodontal care. Progum™ HA is a highly concentrated, non-crosslinked native hyaluronic acid (16 mg HA in a 1 mL pre-filled syringe) with physicochemical parameters optimized to promote soft periodontal tissue regen...
    • Biolevox™ HA

      Product Biolevox™ HA

      The Biolevox™ HA product family is based on hyaluronic acid with carefully selected concentration, viscosity and molecular parameters tailored to specific clinical applications.
      • Biolevox™ HA ONE delivers 120 mg of highly purified HA in a single injection. Its USP is clinically confirmed OA symptom ...
    • Lipotris™

      Product Lipotris™

      Liposomal intra-articular gel composite - new generation viscosupplement which ensures supreme lubrication mechanism. Lipotris™ therapy provides accelerated pain relief with sustainable duration of clinical effect. The TRIAD OF AN IDEAL LUBRICATION provides ultra-low friction ratio between cartilage surfac...
    • Xerthra™ kits

      Product Xerthra™ kits

      Xerthra™ is a family of high-performance separation devices for preparing autologous, blood-derived injectable products. Made from Makrolon® polycarbonate with very low surface energy, Xerthra™ minimizes protein/cell binding to the device surface — unlike tube-based kits — ensuring maximum recovery of plat...
    • Wint™ kit

      Product Wint™ kit

      Wint ™ is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint™ separation device, due to presence of the exclusive borosilicate activator trigge...
    • FLAVYA™

      Product FLAVYA™

      Flavya™ products are injectable medical devices containing native hyaluronic acid (HA). Flavya™ complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin.
      Two v...
    • DKK DERM™ kit

      Product DKK DERM™ kit

      DKK DERM™ kit is designed to obtain an autologous blood-derived product enriched with the DKK-1 protein (DKK-PRP). The DKK DERM™ separation device features an innovative borosilicate platelet activator that selectively induces platelet activation, leading to the release of hig...

    Biovico Sp. z o.o. resources (4)